ADAC brings PET to oncologists
ADAC Laboratories and American Diagnostic Medicine have signed an agreement with the International Oncology Network to offer PET imaging services to the network's 2000 oncologists. This agreement is an offshoot of the "First Nuclear" joint venture
ADAC Laboratories and American Diagnostic Medicine have signed an agreement with the International Oncology Network to offer PET imaging services to the network's 2000 oncologists. This agreement is an offshoot of the "First Nuclear" joint venture between ADAC and ADM.
Any International Oncology Network member can sign up for the First Nuclear program. ADAC will provide the PET scanners and trained technologists to perform diagnostic exams, along with supplies, marketing, state licensing, procedure coding, and other information. ADM will provide the facilities and administrative services.
ADAC has been developing PET scanners for five years. Three years ago, the company introduced C-PET, a dedicated whole-body scanning device. ADM runs programs that let hospitals, freestanding clinics, group practices, and other managed-care providers deliver medical imaging services.
Also this month, ADAC announced results of its second quarter 2000. Revenue was $90 million compared to $87.4 million for second quarter 1999. The company's net income for the quarter was $3.1 million compared to a net loss of $7.9 million in second quarter 1999. ADAC said the second quarter 1999 loss was due to combined pretax restructuring and pretax charges of $18 million.
ADAC received orders for 16 C-PET units during the second quarter of fiscal 2000, compared with orders for 10 units in the first quarter.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.
